Portola Pharmaceuticals

Portola Pharmaceuticals

VISIT US AT BOOTH 611

Portola Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics that could significantly advance the fields of thrombosis and other hematologic diseases. The Company’s two FDA-approved medicines are Bevyxxa® (betrixaban) and Andexxa® coagulation factor Xa (recombinant), inactivated-zhzo. The company also is advancing cerdulatinib, a Syk/JAK inhibitor for hematologic cancers.

Pin It on Pinterest